Anchiano Therapeutics Competitors and Similar CompaniesClear all
Anchiano Therapeutics's competitors and similar companies include enVVeno.
 Anchiano Therapeutics Anchiano Therapeutics is a clinical-stage biotechnology company that develops gene therapies to treat early-stage bladder cancer. |  enVVeno Envveno Medical (formerly known as Hancock Jaffe) is a company developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). | |
Founding Date | Founding Date 2004 | Founding Date 1987 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ | Locations Irvine, US HQ |
Employees | Employees 1912% increase | Employees 1525% increase |
Valuation ($) | Valuation ($) 34.9 m | Valuation ($) 88.4 m |
Financial | ||
Net income | Net income $9.8m (FY, 2017) | Net income ($19.5m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
enVVeno
HQ
Irvine, US
Employees
15↑ 25% increase
Envveno Medical (formerly known as Hancock Jaffe) is a company developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD).
View company